Search results for “Angiopathy” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 983 patents, we discovered top 260 key players by total patent application. F. Hoffmann-La Roche Ltd., Eli Lilly & Co., Novartis AG are dominant in this area. They take 18.11% of the total patent filing.
Switzerland
Patent: 89
Indiana, United States
Patent: 57
Basel-Stadt, Switzerland
Patent: 32
Jiangsu Sheng, China
Patent: 31
Berlin, Germany
Patent: 27
Connecticut, United States
Patent: 20
Massachusetts, United States
Patent: 19
Nordrhein-Westfalen, Germany
Patent: 16
California, United States
Patent: 16
Antwerpen, Belgium
Patent: 15
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 28 patents, we discovered top 14 start-ups by total patent application. Aiviva Biopharma, Inc., Acworth Pharmaceuticals, Inc., Institut National de la Santé et de la Recherche Médicale are active in this area.
STARTUP
California, United States
Patent: 5
STARTUP
Acworth Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 4
STARTUP
DegenRx BV
Noord-Brabant, Netherlands
Patent: 3
STARTUP
Beijing Shi, China
Patent: 2
STARTUP
Massachusetts, United States
Patent: 2
STARTUP
Massachusetts, United States
Patent: 2
STARTUP
California, United States
Patent: 1
STARTUP
ZURICH, Switzerland
Patent: 1
STARTUP
Kanagawa-ken, Japan
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 669 patents applied in the last 5 years. We discover 247 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Eli Lilly & Co., Alnylam Pharmaceuticals, Inc. take 14.20% of patent filing during this period.
Switzerland
Patent: 43
Indiana, United States
Patent: 33
Massachusetts, United States
Patent: 19
Nordrhein-Westfalen, Germany
Patent: 11
Sachsen-Anhalt, Germany
Patent: 8
New York, United States
Patent: 8
New York, United States
Patent: 8
New Jersey, United States
Patent: 7
Guangdong Sheng, China
Patent: 7
Berlin, Germany
Patent: 7
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 669 patents in last 5 years, we discover 208 new entrants. Alnylam Pharmaceuticals, Inc., Applied Therapeutics, Inc., IVERIC bio, Inc. are the most active new entrants in this area.
Massachusetts, United States
Patent: 19
New York, United States
Patent: 8
New Jersey, United States
Patent: 7
United States
Patent: 7
Uttar Pradesh, India
Patent: 5
Massachusetts, United States
Patent: 5
undefined undefined
Patent: 5
Jiangsu Sheng, China
Patent: 5
Bayern, Germany
Patent: 4
Research Institutions
Order by:
Innovation Intensity
With the analysis among 179 patents, we discovered top 73 universities and scientific research institutions by total patent application. The Trustees of Columbia University in The City of New York, University of Washington, Washington University in St. Louis are dominant in this area. They take 16.76% of the total patent filing.
New York, United States
Patent: 16
Washington, United States
Patent: 6
Missouri, United States
Patent: 6
United States
Patent: 4
Liaoning Sheng, China
Patent: 4
Beijing Shi, China
Patent: 3
Nebraska, United States
Patent: 3
Shanghai Shi, China
Patent: 3
Shaanxi Sheng, China
Patent: 3
United States
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: